Vitamin-based Life-extension therapy: ATRA (A form of Vitamin-A) inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 22/May/2017, 11.52 pm

Vitamin-based therapy for pulmonary arterial hypertension: Cholecalciferol (a form of Vitamin-D) inhibits the development of pulmonary arterial hypertension via down regulation of Notch3 and its target gene Hes-5, 22/May/2017, 9.53 am
May 22, 2017
Amino-acid based therapy for Inflammatory bowel disease: Leucine, the branched chain amino acid, decreases the expression of oncostatin M, attenuates activation of oncostatin M- oncostatin M receptor pathway in inflamed colon tissues, inhibits inflammatory gene expression, attenuates colonic pathogenesis, and inhibits the progression of inflammatory bowel disease and colitis via down regulation of its target gene, 22/May/2017, 11.50 pm
May 22, 2017
Show all

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports, for the first time, that: Vitamin-based Life-extension therapy: ATRA (A form of Vitamin-A) inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span

[easy_payment currency=”USD”]


Research findings to Therapeutic opportunity: 

ATRA (A form of Vitamin-A), by  increasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).

Figure 1. Mechanistic insight into how ATRA (A form of Vitamin-A) may extend lifespan. ATRA may promote longevity by suppressing the expression of p70 S6 kInase

Thus, pharmacological formulations encompassing ATRA (A form of Vitamin-A) or its analogs, either alone or in combination with any of the known longevity-promoting compound(s), may be used to extend the lifespan of an individual (figs. 1-2).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How  ATRA (A form of Vitamin-A) decreases p70 S6 Kinase expression and promotes mammalian life span

# Research cooperation

Amount: $50#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L.,   Vitamin-based derived Life-extension therapy: ATRA (A form of Vitamin-A) inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 22/May/2017, 11.52 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.